Literature DB >> 9163663

Comparison of guidelines and self-management plans in asthma.

R J Meijer1, H A Kerstjens, D S Postma.   

Abstract

Since the rise in asthma mortality and morbidity, many guidelines and self-management plans have been published. Many of these guidelines and self-management plans are not, however, based on results of previous studies but on the opinion of experts. We compared the five most frequently cited asthma guidelines concerning treatment steps and self-management plans with special regard to peak expiratory flow (PEF)-guided plans in asthma. We also compared results of published studies with asthma-management in the context of the guidelines. Classification of asthma severity differed considerably between the guidelines. This was also true for PEF-guided patient self-management plans. Although there was agreement on the type of drug to be used, guidelines varied with respect to when to use the drug, the "best" strategy to increase the dose, and the maximum dose. The studies available on self-management do not make it possible to determine which part of the programme is most important or cost-effective. The latter is an important issue.

Entities:  

Mesh:

Year:  1997        PMID: 9163663     DOI: 10.1183/09031936.97.10051163

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  8 in total

1.  Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma.

Authors:  R J Meijer; H A Kerstjens; L R Arends; H F Kauffman; G H Koëter; D S Postma
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

2.  Diurnal variability--time to change asthma guidelines?

Authors:  H Reddel; C Jenkins; A Woolcock
Journal:  BMJ       Date:  1999-07-03

Review 3.  Severe acute asthma.

Authors:  S Salmeron; M Bard; F X Blanc; A Ellrodt
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 8.667

4.  Self management in asthma care. Professionals must rethink their role if they are to guide patients successfully.

Authors:  B Thoonen; C van Weel
Journal:  BMJ       Date:  2000-12-16

5.  Guidelines update: where do the new therapies fit in the management of asthma? NHLBI and WHO Global Initiative for Asthma.

Authors:  J P Kemp
Journal:  Drugs       Date:  2000       Impact factor: 9.546

Review 6.  Montelukast: a review of its therapeutic potential in persistent asthma.

Authors:  B Jarvis; A Markham
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

Review 7.  Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma.

Authors:  B Jarvis; D Faulds
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

8.  Clustered randomised trial of an intervention to improve the management of asthma: Greenwich asthma study.

Authors:  U N Premaratne; J A Sterne; G B Marks; J R Webb; H Azima; P G Burney
Journal:  BMJ       Date:  1999-05-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.